Literature DB >> 23093098

Estimation of radiation dose and risk to children undergoing cardiac catheterization for the treatment of a congenital heart disease using Monte Carlo simulations.

Emmanuel Yakoumakis1, Helen Kostopoulou, Triantafilia Makri, Anastastios Dimitriadis, Evaggelos Georgiou, Ioannis Tsalafoutas.   

Abstract

BACKGROUND: Children diagnosed with congenital heart disease often undergo cardiac catheterization for their treatment, which involves the use of ionizing radiation and therefore a risk of radiation-induced cancer.
OBJECTIVE: The purpose of this study was to calculate the effective and equivalent organ doses (H(T)) in those children and estimate the risk of exposure-induced death.
MATERIALS AND METHODS: Fifty-three children were divided into three groups: atrial septal defect (ASD), ventricular septal defect (VSD) and patent ductus arteriosus (PDA). In all procedures, the exposure conditions and the dose-area product meters readings were recorded for each individual acquisition. Monte Carlo simulations were run using the PCXMC 2.0 code and mathematical phantoms simulating a child's anatomy. The H(T) values to all irradiated organs and the resulting E and risk of exposure-induced death values were calculated.
RESULTS: The average dose-area product values were, respectively, 40 ± 12 Gy·cm(2) for the ASD, 17.5 ± 0.7 Gy·cm(2) for the VSD and 9.5 ± 1 Gy·cm(2) for the PDA group. The average E values were 40 ± 12, 22 ± 2.5 and 17 ± 3.6 mSv for ASD, VSD and PDA groups, respectively. The respective estimated risk of exposure-induced death values per procedure were 0.109, 0.106 and 0.067%.
CONCLUSION: Cardiac catheterizations in children involve a considerable risk for radiation-induced cancer that has to be further reduced.

Entities:  

Mesh:

Year:  2012        PMID: 23093098     DOI: 10.1007/s00247-012-2510-3

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  16 in total

1.  Differences in effective dose estimation from dose-area product and entrance surface dose measurements in intravenous urography.

Authors:  E Yakoumakis; I A Tsalafoutas; D Nikolaou; I Nazos; E Koulentianos; C Proukakis
Journal:  Br J Radiol       Date:  2001-08       Impact factor: 3.039

2.  A study of the application of paediatric reference levels.

Authors:  A Montgomery; C J Martin
Journal:  Br J Radiol       Date:  2000-10       Impact factor: 3.039

3.  Patient doses from fluoroscopically guided cardiac procedures in pediatrics.

Authors:  L C Martinez; E Vano; F Gutierrez; C Rodriguez; R Gilarranz; M J Manzanas
Journal:  Phys Med Biol       Date:  2007-07-24       Impact factor: 3.609

4.  Patient-specific dose and radiation risk estimation in pediatric cardiac catheterization.

Authors:  Klaus Bacher; Evelien Bogaert; Régine Lapere; Daniël De Wolf; Hubert Thierens
Journal:  Circulation       Date:  2004-12-20       Impact factor: 29.690

5.  Closure of atrial septal defects with the Amplatzer occlusion device: preliminary results.

Authors:  B D Thanopoulos; C V Laskari; G S Tsaousis; A Zarayelyan; A Vekiou; G S Papadopoulos
Journal:  J Am Coll Cardiol       Date:  1998-04       Impact factor: 24.094

6.  Radiation exposure to children during coil occlusion of the patent ductus arteriosus.

Authors:  J D Moore; D Shim; J Sweet; K L Arheart; R H Beekman
Journal:  Catheter Cardiovasc Interv       Date:  1999-08       Impact factor: 2.692

7.  Calculation of organ doses in x-ray examinations of premature babies.

Authors:  Kristien Smans; Markku Tapiovaara; Mieke Cannie; Lara Struelens; Filip Vanhavere; Marleen Smet; Hilde Bosmans
Journal:  Med Phys       Date:  2008-02       Impact factor: 4.071

8.  Radiation dose survey in a paediatric cardiac catheterisation laboratory equipped with flat-panel detectors.

Authors:  O Dragusin; M Gewillig; W Desmet; K Smans; L Struelens; H Bosmans
Journal:  Radiat Prot Dosimetry       Date:  2008-02-18       Impact factor: 0.972

9.  Monte Carlo calculations for assessment of radiation dose to patients with congenital heart defects and to staff during cardiac catheterizations.

Authors:  F W Schultz; J Geleijns; F M Spoelstra; J Zoetelief
Journal:  Br J Radiol       Date:  2003-09       Impact factor: 3.039

10.  Estimation of children's radiation dose from cardiac catheterisations, performed for the diagnosis or the treatment of a congenital heart disease using TLD dosimetry and Monte Carlo simulation.

Authors:  E N Yakoumakis; G I Gialousis; Despina Papadopoulou; Triantafillia Makri; Zografia Pappouli; Nikolaos Yakoumakis; Panayotis Papagiannis; Evangelos Georgiou
Journal:  J Radiol Prot       Date:  2009-05-19       Impact factor: 1.394

View more
  5 in total

1.  Cumulative radiation exposure in pediatric patients with congenital heart disease.

Authors:  Mark A Walsh; Michelle Noga; Jennifer Rutledge
Journal:  Pediatr Cardiol       Date:  2014-08-15       Impact factor: 1.655

2.  The lateral plane delivers higher dose than the frontal plane in biplane cardiac catheterization systems.

Authors:  Osamah Aldoss; Sonali Patel; Kyle Harris; Abhay Divekar
Journal:  Pediatr Cardiol       Date:  2015-01-14       Impact factor: 1.655

3.  Patient radiation exposure in a modern, large-volume, pediatric cardiac catheterization laboratory.

Authors:  Andrew C Glatz; Akash Patel; Xiaowei Zhu; Yoav Dori; Brian D Hanna; Matthew J Gillespie; Jonathan J Rome
Journal:  Pediatr Cardiol       Date:  2014-01-18       Impact factor: 1.655

4.  Cumulative radiation exposure and cancer risk estimation in children with heart disease.

Authors:  Jason N Johnson; Christoph P Hornik; Jennifer S Li; Daniel K Benjamin; Terry T Yoshizumi; Robert E Reiman; Donald P Frush; Kevin D Hill
Journal:  Circulation       Date:  2014-06-09       Impact factor: 29.690

5.  Substantial radiation reduction in pediatric and adult congenital heart disease interventions with a novel X-ray imaging technology.

Authors:  Nikolaus A Haas; Christoph M Happel; Maria Mauti; Cherif Sahyoun; Lea Z Tebart; Deniz Kececioglu; Kai Thorsten Laser
Journal:  Int J Cardiol Heart Vasc       Date:  2015-01-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.